Full Interview with Scott Brunner from Alliance for Pharmacy Compounding скачать в хорошем качестве

Full Interview with Scott Brunner from Alliance for Pharmacy Compounding

Join us in a compelling conversation with Scott Brunner, CEO of The Alliance for Pharmacy Compounding, as he dives deep into the mission and advocacy efforts of the organization. In this insightful discussion, Scott outlines the critical role of accreditations in ensuring the safety and efficacy of compounded medications. Amidst the GLP-1 shortage, he addresses the significant challenges faced by compounding pharmacies, particularly regarding the ability to compound semaglutide and tirzepatide. This video also explores the contentious efforts by Eli Lilly to remove tirzepatide from the FDA's drug shortage list, a move that has sparked legal and ethical debates within the pharmaceutical industry. Learn about the vital advocacy work that supports patient access to essential medications through compounding, especially during shortages that impact countless individuals. A must-watch for healthcare professionals and patients alike who rely on or are interested in the world of compounding. GLP-1 FAQs: https://tccompound.com/glp1-faq/ #GLP1 #compoundingpharmacy #APC #NewJersey #NewYork